Cannabis as a substitute for alcohol and other drugs: A dispensary-based survey of substitution effect in Canadian medical cannabis patients

Addiction Research and Theory

Volumn 21, Issue 5, 2013, Pages 435-442

  Lucas, Philippe ^a   Reiman, Amanda ^b   Earleywine, Mitch ^c   Mcgowan, Stephanie K ^d   Oleson, Megan ^e   Coward, Michael P ^f   Thomas, Brian ^g  

^a UNIVERSITY OF VICTORIA   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d Vancouver Island Compassion Society   (Canada)

^e BC Compassion Club Society   (Canada)

^f Vancouver Dispensary Society   (Canada)

^g Department of Medical Cannabis Research   (Canada)

Author keywords

Addiction; Cannabis; Dispensary; Marijuana; Substitution effect

Indexed keywords

EID: 84882779890     PISSN: 16066359     EISSN: 14767392     Source Type: Journal    
DOI: 10.3109/16066359.2012.733465     Document Type: Article

References (37)

1. Aharonovich, E., Garawi, F., Bisaga, A., Brooks, D., Raby, W.N., Rubin, E., Australian Institute of Health and Welfare (2002) 2001 National Drug Strategy Household Survey: First results. AIHW cat. no. PHE 35. Canberra: AIHW (Drug Statistics Series No. 9). Retrieved from http:// www.aihw.gov.au/ publication-detail/?id=6442467340
2. Balerio, G., Aso, N.E., & Maldonado, R. (2006). Role of the cannabinoid system in the effects induced by nicotine on anxiety-like behaviour in mice. Psychopharmacology, 184, 504-513
3. Belle-Isle, L. (2006). Cannabis as therapy for people living with HIV/AIDS; Our Right, Our Choice. Canadian AIDS Society. Retrieved from http://www.cdnaids.ca/files.nsf/pages/cannabis-english/$file/ cannabis-english.pdf
4. Blume, L., Bass, C., Childers, S., Dalton, G., Richardson, J., Selley, D., Howlett, A. (2011). Cannabinoid receptor interacting protein 1A (CRIP1A) modulates striatal neuropharmacology and signal transduction in cannabinoid, dopamine and opioid receptor systems (2011). 21st Annual Symposium on the Cannabinoids (pp. 2-21). Research Triangle Park, NC: International Cannabinoid Research Society
5. Damaj, M., & Lichtman, A. (2011) Nicotine reward: A role for CB2 receptors? 21st Annual Symposium on the Cannabinoids (p. 45). Research Triangle Park, NC: International Cannabinoid Research Society
6. Devkota, S., & Mukhopadhyay, S. (2011) Cannabinoid-ethanol interaction in the regulation of developing neurogenesis in zebrafish brain. 21st Annual Symposium on the Cannabinoids (pp. 3-8). Research Triangle Park, NC: International Cannabinoid Research Society
7. Dhalla, I., Mamdani, M., & Sivilotti, M. (2009). Prescribing of opioid analgesics and related mortality before and after the introduction of long-Acting oxycodone. CMAJ, 181, 891-896
8. Earleywine, M., & Smucker Barnwell, S. (2007). Decreased respiratory symptoms in cannabis users who vaporize. Harm Reduction Journal, 4, 11
9. Fischer, B., Rehm, J., Goldman, B., & Popova, S. (2008). Nonmedical use of prescription opioids and public health in Canada: An urgent call for research and intervention development. Canadian Jounal on Public Health, 99, 182-184
10. Gieringer, D. (2006). 10th Anniversary of Prop. 215; California Leads, Feds Still Lag on Medical Marijuana. Oakland, CA. Retrieved from California NORML website: Http://canorml. org/news/10thAnniversaryProp215.htm
11. Grinspoon, L. (1999). Medical marijuana in a time of prohibition. International Journal of Drug Policy, 10, 145-156
12. Grinspoon, L., & Bakalar, J.B. (1993). Marijuana the forbidden medicine. New Haven, CT: Yale University Press
13. Howard, J., Banks, S., Golinski, M., & Stinchcomb, A. (2011). Development of cannabidiol prodrugs for use with microneedles for the treatment of alcohol use disorders. 21st Annual Symposium on the Cannabinoids (pp. 3-18). Research Triangle Park, NC: International Cannabinoid Research Society
14. Hursh, S.R., Galuska, C.M., Winger, G., & Woods, J.H. (2005). The economics of drug abuse: A quantitative assessment of drug demand. Molecular Interventions, 5, 20-28
15. Labigalini Jr, E., Rodrigues, L.R., & Da Silveira, D.X. (1999). Therapeutic use of cannabis by crack addicts in Brazil. Journal of Psychoactive Drugs, 31, 451-455
16. Levin, F.R. (2006). Concurrent cannabis use during treatment for comorbid ADHD and cocaine dependence: Effects on outcome. American Journal of Drug and Alcohol Abuse, 32, 629-635
17. Liput, D., Pendergast, M., & Nixon, K. (2011). Endocannabinoid modulation attenuates ethanol-induced neurodegeneration during withdrawal. 21st Annual Symposium on the Cannabinoids (p. 32). Research Triangle Park, NC: International Cannabinoid Research Society
18. Lopez-Quintero, C., Hasin, D.S., de Los Cobos, J.P., Pines, A., Wang, S., Grant, B.F., & Blanco, C. (2011). Probability and predictors of remission from life-Time nicotine, alcohol, cannabis or cocaine dependence: Results from the National Epidemiologic Survey on Alcohol and Related Conditions. Addiction, 106, 657-669
19. Los Angeles Times (2009). No quick action seen on L.A. marijuana dispensaries. Retrieved from http://www.latimes. com/news/local/la-me-medical- marijuana4-2009nov04,0,4490 002.story
20. Lucas, R.V. (2002). Victoria Registry No. 113701C, (Prov. Ct. B.C; July 5, 2002
21. Lucas, P. (2008). Regulating compassion; an overview of Health Canada's medical cannabis policy and practice. Harm Reduction Journal, 5, 5
22. Lucas, P. (2009). Moral regulation and the presumption of guilt in Health Canada's medical cannabis policy and practice. International Journal of Drug Policy, 20, 296-303
23. Lucas, P. (2012). It can't hurt to ask; a patient-centered quality of service assessment of Health Canada's medical cannabis policy and program. Harm Reduction Journal, 9, 2
24. Maitra, R., Bortoff, K., Pan, H., Reggio, P., & Seltzman, H. (2011). Inhibition of alcoholic hepatic steatosis by a Type 1 Cannabinoid receptor neutral antagonist. 21st Annual Symposium on the Cannabinoids (p. 23). Research Triangle Park, NC: International Cannabinoid Research Society
25. Mikuriya, T. (2004). Cannabis as a substitute for alcohol: A harm reduction approach. Journal of Cannabis Therapeutics, 4, 79-93
26. Model, K.E. (1993). The effect of marijuana decriminalization on hospital emergency drug episodes: 1975-1978. Journal of the American Statistical Association, 88, 737-747
27. Moore, T.J., Cohen, M.R., & Furberg, C.D. (2007). Serious adverse drug events reported to the Food and Drug Administration, 1998-2005. Archives of Internal Medicine, 167, 1752-1759
28. Muldoon, P., Lichtman, A., & Damaj, I. (2011). The role of 2-AG endocannabinoid neurotransmission in nicotine reward and withdrawal (2011). 21st Annual Symposium on the Cannabinoids (pp. 3-24). Research Triangle Park, NC: International Cannabinoid Research Society
29. Nunberg, H., Kilmer, B., Pacula, R., & Burgdorf, J. (2011). An analysis of applicants presenting to a medical marijuana specialty practice in California. Journal of Drug Policy Analysis, 4, 1
30. Perkonigg, A., Goodwin, R.D., Fiedler, A., Behrendt, S., Beesdo, K., Lieb, R., & Wittchen, H.U. (2008). The natural course of cannabis use, abuse and dependence during the first decades of life. Addiction, 103, 439-449
31. Ramesh, D., Owens, R., Kinsey, S., Cravatt, B., Sim-Selley, L., & Lichtman, A. (2011). Effects of chronic manipulation of the endocannabinoid system on precipitated opioid withdrawal. 21st Annual Symposium on the Cannabinoids (pp. 3-22). Research Triangle Park, NC: International Cannabinoid Research Society
32. Reiman, A. (2006). Cannabis care: Medical cannabis facilities as health service providers (Dissertation). School of Social Welfare/Alcohol Research Group, University of California, Berkeley
33. Reiman, A. (2009). Cannabis as a substitute for alcohol and other drugs. Harm Reduction Journal, 6, 35
34. Schwartz, R. (2010). Medical marijuana users in substance abuse treatment. Harm Reduction Journal, 7, 3
35. Statistics Canada (2012). Individuals by total income level, by province and territory. Retrieved from http://www. statcan.gc.ca/tables-Tableaux/sum-som/ l01/cst01/famil105aeng. Htm
36. Substance Abuse and Mental Health Services Administration, (2007). Results from the 2006 National Survey on Drug Use and Health: National Findings (NSDUH Series H-32, DHHS Publication No. SMA 07-4293). Rockville, MD: Office of Applied Studies.
37. United Nations Office for Drug Control and Crime Prevention (2001). World drug report 2001 (pp. 30-32). Oxford: Oxford University Press